Proton transport inhibitors as potentially selective anticancer drugs

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2127-2136

  Harguindey, Salvador ^a   Arranz, Jose Luis ^a   Wahl, Miriam L ^b   Orive, Gorka ^c   Reshkin, Stephan J ^d  

^a Institute of Clinical Biology and Metabolism   (Spain)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

Cancer angiogenesis; Cancer etiopathogenesis; Cancer strategy and treatment; Multiple drug resistance (MDR); pH and cancer; Proton transport in cancer; Review

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 (N,N DIMETHYL)AMILORIDE; 5 (N,N HEXAMETHYLENE)AMILORIDE; ACETAZOLAMIDE; AMILORIDE; ANGIOSTATIN; ANTINEOPLASTIC AGENT; BAFILOMYCIN A1; CAMPTOTHECIN; CARBONATE DEHYDRATASE; CARIPORIDE; CASPASE; CINNAMIC ACID; CISPLATIN; DOXORUBICIN; GLYCOPROTEIN P; HYPOXIA INDUCIBLE FACTOR; LOBATAMIDE DERIVATIVE; LONIDAMINE; MONOCARBOXYLATE TRANSPORTER 1; OMEPRAZOLE; OXIMIDINE DERIVATIVE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; QUERCETIN; RESVERATROL; SALCYLIHALAMIDE; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; ZONIPORIDE;

ACIDOSIS; ALKALINIZATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL INVASION; CELL MOTILITY; CELL PH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; METASTASIS INHIBITION; MICROENVIRONMENT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PROTON PUMPS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 67650921941     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes, FASEB J 14: 2185-2219, 2006.
2. Izumi H, Torigoe T, Ishiguch H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakmi T, Yoshida T, Nomoto M and Kohno K: Cellular pH regulators: potentially promising molecular targets of cancer chemotherapy. Cancer Treat Rev 29: 541-549, 2003. (Pubitemid 37428326)
3. + exchanger in metastasis. Nature Rev Cancer 5: 786-795, 2005. (Pubitemid 41400778)
4. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Bioch Biopyhs Acta Revs Cancer 1756: 1-24, 2005.
5. i homeostasis in apoptosis: origins and roles. Cell Death Diff 11: 953-961, 2004. (Pubitemid 39232355)
6. Gatenby RA, Gawlinski ET, Tangen CM, Flanigan RC and Crawford ED: The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy. Cancer Res 62: 5218-5222, 2002. (Pubitemid 35024593)
7. Poüysségur J, Dayan F and Mazure NM: Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441: 437-443, 2006. (Pubitemid 44050138)
8. Thangaraju M, Sharma K, Lui D, Shen S and Srikant H: Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Res 59(7): 1649-1654, 1999. (Pubitemid 29160139)
9. +-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anticancer Drugs 3: 237-243, 2002.
10. - symporter, induces apoptosis of human colon cancer cells lines in vitro. Oncol Rep 8: 821-824, 2001. (Pubitemid 33758130)
11. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB and Owen CS: Regulation of intracellular pH in human melanoma: potential therapeutic implications Mol Cancer Therap 1: 617-628. 2002.
12. +-linked monocarboxilate transporter (MCT/SLC16A1): a potential therapeutic target for high risk neuroblastoma. Mol Pharmacol 70(6): 2108-2115, 2006.
13. Yamagata M, Hasuda K, Stamato T and Tannock IF: The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Brit J Cancer 77: 1726-1731, 1998. (Pubitemid 28254604)
14. Moser TL, Stack MS, Asplin I, Enghild, LL, Hojrup, Everitt L, Hubchak S, Scnaoer HW and Pizzo SV: Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 96: 2811-2816, 1999. (Pubitemid 29148800)
15. Wahl, ML and Grant DS: Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH. Gen Pharmacol 35: 277-285, 2002.
16. +-ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells (HUVECs). Mol cancer Res 1: 931-939, 2003. (Pubitemid 37463349)
17. +-coupled alanine transporting in rat hepatocytes. Biochem Biophys Acta 938: 386-394, 1988. (Pubitemid 18067089)
18. - exchange. Eur J Cancer 29A: 132-137, 1992.
19. Swietach P, Vaughan-Jones RD and Harris AL: Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26: 299-310, 2007.
20. Parkkila S: Significance of pH regulation and carbonic anhydrases in tumor progression and implications for diagnostic and therapeutic approaches. BJU Int 101(S4):16-21, 2008.
21. Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC and Pouysségur J: Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69(1): 358-368, 2009.
22. + exchanger. Blood 95: 1427-1434, 2000.
23. + exchanger: induction mechanisms and treatment implications. Apoptosis 5: 87-89, 2000. (Pubitemid 30146394)
24. + exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. Int J Cancer 115: 924-929, 2005. (Pubitemid 40791833)
25. Di Sario A, Bendia E, Omenetti A, De Minicis S, Marzioni M, Kleemann HW, Candelaresi C, Saccomanno S, Alpini G and Benedetti A: Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. Digest and Liv Dis 39: 60-69, 2007. (Pubitemid 46024544)
26. Rauch C, Wood E, Dillon E and Harguindey S: Cell membrane, cytosolic pH and drug transport in cancer and MDR: its physics, biochemistry and molecular biology. In: Multiple Drug Resistance. Franck Columbus (ed.). New York, Nova Science Publishers in press, 2009.
27. i homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochem 32: 11042-11056, 1993. (Pubitemid 23332011)
28. Thews O, Gassner B, Kelleher DK, Schwerdt G and Gekle M: Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8(2): 143-152, 2006.
29. Shimizu S, Eguchi Y, Kamike W and Funahashai Y: Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 95: 1455-1459, 1998. (Pubitemid 28103413)
30. DiGiammarino J, Lee AS, Cadwel C, Zhang W, Bothner B, Ribeiro RC, Zambetti G and Kriwacki RW: A novel mechanism of tumorogenesis involving pH-dependent desestabilization of a mutant p53 tetramer. Nature Struct Biol 9(1): 12-16, 2002. (Pubitemid 34049172)
31. +-mediated unifying approach: pH-related and pH-unrelated mechanisms. Critical Rev Oncog 6(1): 1-33, 1995.
32. Kozin SV, Shkarin P and Gerweck LE: The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acids chemotherapeutics. Cancer Res 61(12): 4740-4743, 2001. (Pubitemid 32691884)
33. + exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: New therapeutic possibilities and potential dangers. Curr Alzh Res 4(1): 53-65, 2007. (Pubitemid 46293884)
34. De Milito A and Fais S: Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 1(6): 779-786, 2005.
35. Murakami T, Shibuya I, Ise T, Zhe-Sheng Ch, Akiyama S-i, Nakagawa M., Izumi H, Nakamura T, Matsuo K-i, Yamada Y and Kohno K: Elevated expression of vacuolar proton pump genes and cellular pH in cisplatin resistance. Int J Cancer 93(6): 869-874, 2001. (Pubitemid 32756757)
36. + exchanger (NHE) isoform 1 in human breast cancer cells. Clin Cancer Res 9: 2366-2373, 2003.
37. Matsuyama S, Llopis J, Deveraux QL, Tsien RY and Reed JC: Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nature Cell Biol 2: 318-325, 2000. (Pubitemid 30781087)
38. Murray CM, Hutchinson R, Bantick JR, Murray CM, Hutchinson R, Bantick JR, Belfield GP, Benjamin AD, Brazma D, Bundick RV, Cook ID, Craggs RI, Edwards S, Evans LR, Harrison R, Holness E, Jackson AP, Jackson CG, Kingston LP, Perry, MWD, Ross ARJ, Rugman PA, Sidhu SS, Sullivan M, Taylor-Fishwick DA, Walker CP, Whitehead YM, Wilkinson DJ, Wright A and Donald DK: Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat Chem Biol 1(7): 371-376, 2005.
39. Adams DJ, Wahl ML, Flowers JL, Sem B, Colvin M, Dewhirst MW, Manikumar G and Wani MC: Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient. Cancer Chemother Pharmacol 57: 145-154, 2006.
40. Thiebaut F, Currier SJ, Whitaker J, RP Haugland RP, Gottesman MM, I Pastan I and Willingham MC: Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem 35(5): 685-690, 1990. (Pubitemid 20146213)
41. + exchange inhibitors cariporide mesilate and (3-methanesulfonyl-4-piperidino-benzoyl) guanidine methanesulfonate. Arzneimittelforschung 47: 1204-1207, 1997. (Pubitemid 27514556)
42. + exchanger. Leukemia Res 31: 507-514, 2007. (Pubitemid 46198933)
43. De Milito A and Fais S: Proton pump inhibitors may reduce tumour resistance. Drug Expert Opin Pharmacother 6(7): 1-6, 2005. (Pubitemid 40959470)
44. Gatenby RA and Gillies RJ: A microenvironmental model of carcinogenesis. Nat Rev Cancer 8: 56-61, 2008.
45. Hsu PP and Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707, 2008.
46. Kroemer G and Pouyssegur J: Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482, 2008. (Pubitemid 351766797)
47. + antiporter in cancer angiogenesis and antiangiogenesis. Br J Cancer 89: 1395-1399, 2003. (Pubitemid 37386588)
48. Taves J, Rastedt D, Canine J, Mork D, Wallert MA and Provost JJ: Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts. Arch Biochem Biophys 477: 60-66, 2008.
49. Giusti I, D'Ascenzo S, Millimaggi D, Taraboletti G, Carta G, Franceschini N, Pavan A and Dolo V: Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 10(5): 481-488, 2008. (Pubitemid 351657390)
50. Kellen JA, Mirakian A and Kolin A: Antimetastatic effect of amiloride in an animal tumor model. Anticancer Res 8: 1373-1376. (Pubitemid 19045931)
51. + antiporter inhibitors as a novel approach to cancer treatment. In: Amiloride and its Analogs: Unique Cation Transport Inhibitors. Cragoe EJ Jr, Kleyman TH and Simchowitz RL (eds.). New York, VCH Publishers Inc, pp. 317-334, 1992.
52. McLean LA, Roscoe J, Gorin FA and Cala PM: Malignant gliomas display altered pH regulation by the Na/H exchanger compared to non-transformed astrocytes. Am J Physiol 278(Cell Physiol 47): C676-C688, 2000. (Pubitemid 30211300)
53. Rofstad EK: Microenvironment-induced cancer metastasis. Int J Radiat Biol 76: 589-605, 2000.
54. Moellering RE, Black KC, Krishnamurty C, Baggett BK, Stafford P, Rain M, Gatenby RA and Gillies RJ: Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metast 25: 411-425, 2008.
55. Martinez-Zaguilán R, Seftor EA, Seftor RE, Chu YW, Gillies RJ and Hendrix MJ: Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metast 14: 176-186, 1996. (Pubitemid 26074280)
56. Chen YX and O'Brien ER: Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity. Can J Physiol Pharmacol 81: 730-739, 2003.
57. Schlappack OK, Zimmermann A and Hill RP: Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer 64: 663-670 1991.
58. Rofstad EK, Mathiesen B, Kindem K and Galappathi K: Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66: 6699-6707, 2006. (Pubitemid 44085627)
59. Raghunand N, Gatenby RA and Gillies RJ: Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76: S11-S22, 2003. (Pubitemid 39530312)
60. Basbaum CB and Werb Z: Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8: 731-738,1996. (Pubitemid 26381732)
61. Sloane BF, Sameni M, Podgorski I, Cavallo-Medved D and Moin K: Functional imaging of tumor proteolysis. Annu Rev Pharmacol Toxicol 46: 301-315, 2006.
62. Kraus M and Wolf B: Implications of acidic tumor microenvironment for neoplastic growth and cancer treatment: a computer analysis. Tumour Biol 17: 133-154, 1996. (Pubitemid 26150508)
63. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B and Gillies RJ: Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66: 5216-5223, 2006. (Pubitemid 43844945)
64. Briozzo P, Morisset M, Capony F, Rougeot C and Rochefort H: In vitro degradation of extracellular matrix with Mr 52.000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692, 1988.
65. Rozhin J, Sameni M, Ziegler G and Sloane BF: Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 54: 6517-6525, 1994.
66. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 279: 26991-27007, 2004. (Pubitemid 38812535)
67. Kato, Y, Nakayama Y, Umeda M and Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic cell lines. J Biol Chem 267: 11424-11430, 1992.
68. Chen KH, Tung PY, Wu JC, Chen Y, Chen PC, Huang SH and Wang SM: An acidic extracellular pH induces Src kinase-dependent loss of beta-catenin from the adherens junction. Cancer Lett 267: 37-48, 2008.
69. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B and Jain RK: Hypoxia and acidosis independently upregulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61: 6020-6024, 2001. (Pubitemid 32762531)
70. Shi Q, Le X, Wang B, Abbruzzese JL, Xiong Q, He Y and Xie K: Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 20: 3751-3756, 2001. (Pubitemid 32624967)
71. Xu L, Fukumura D and Jain RK: Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 277: 11368-11374, 2002. (Pubitemid 34952903)
72. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A and Dolo V: Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 5: 96-103, 2006.
73. Xu L and Fidler IJ: Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 60: 4610-4616, 2000. (Pubitemid 32103647)
74. Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ and Dinney CP: Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res 9: 2786-2797, 2003. (Pubitemid 36842125)
75. Severin T, Müller B, Giese G, Uhl B, Wolf B, Hauschildt S and Kreutz W: pH-dependent LAK cell cytotoxicity. Tumour Biol 15: 304-310, 1994.
76. Loeffler DA, Juneau PL and Heppner GH: Natural killer-cell activity under conditions reflective of tumor micro-environment. Int J Cancer 48: 895-899, 1991.
77. Fischer B, Müller B, Fischer KG, Baur N and Kreutz W: Acidic pH inhibits non-MHC-restricted killer cell functions. Clin Immunol 96: 252-263, 2000a. (Pubitemid 30677774)
78. Fischer B, Müller B, Fisch P and Kreutz W: An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother 23: 196-207, 2000b. (Pubitemid 30165169)
79. Harguindey S: Hydrogen ion dynamics and cancer: an appraisal. Med Pediatr Oncol 10: 217-236, 1982. (Pubitemid 12081287)
80. Anghlieri LJ: Tumor growth inhibition by ammonium chloride induced acidosis. Int J Pharmacol Biopharm 12: 320-326, 1975.
81. Everson TC and Cole WH: Spontaneous regression of cancer. Philadelphia-London, WB Saunders, 1966.
82. Mahoney EM: Complete regression of vesical carcinoma following urinary diversion. Am J Surg 100: 133 136, 1960.
83. + antiporter in oncology in the light of the spontaneous regression of cancer and cell metabolism. Med Hypoth 39: 229-237, 1992.
84. Gatenby RA and Gawlinski ET: Mathematical models of tumour invasion mediated by transformation-induced alteration of microenvironmental pH. In: The Tumor Microenvironment: Causes and Consequences of Hypoxia and Acidity. Novartis Foundation Symposium 240. Gillies RJ (ed.). Chichester, John Wiley & Sons, Ltd., pp. 85-96, 2001. (Pubitemid 33603781)
85. Vincent AM, TenBroecke M and Maiese K: Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death. J Neurobiol 40(2): 171-184, 1999. (Pubitemid 29343302)
86. Harguindey S, Orive G, Cacabelos R, Melendez Hevia E, Diaz de Otazu R and Anitua E: An integral approach to the etiopathogenesis of human neurodegeneratives diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS). Neuropsych Dis Treat 4(6): 1073-1087, 2008.
87. Marches R, Vitetta ES and Uhr. A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. PNAS 98(6): 3434-3439, 2001.